Genix Pharmaceuticals Corporation (GENPF)

Genix Pharmaceuticals Balance Sheet

Financials in millions CAD. Fiscal year is November - October.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020
Cash & Equivalents	0	0.01	0.01	0.01	0.14	0.7
Cash & Short-Term Investments	0	0.01	0.01	0.01	0.14	0.7
Cash Growth	-54.69%	-1.30%	25.51%	-93.32%	-80.07%	2122.24%
Other Receivables	0	0.01	0	0.02	0	0.01
Receivables	0	0.01	0	0.02	0	0.01
Inventory	-	-	0.16	0.17	0	-
Prepaid Expenses	0.02	0.02	0.04	0.04	0.04	0.01
Total Current Assets	0.02	0.04	0.22	0.24	0.19	0.72
Property, Plant & Equipment	-	-	-	0	0.03	-
Other Intangible Assets	0.01	0.01	0.01	4.01	4.55	4.63
Total Assets	0.03	0.05	0.22	4.25	4.77	5.35
Accounts Payable	0.17	0.15	0.25	0.21	0.01	0.12
Accrued Expenses	0.02	0.02	0.02	0.02	0.03	0.02
Short-Term Debt	1.02	0.82	0.51	0.18	0.02	0.02
Current Portion of Leases	-	-	-	0	0.02	-
Other Current Liabilities	0.24	0.24	0.58	0.64	0.66	0.2
Total Current Liabilities	1.45	1.23	1.36	1.05	0.74	0.35
Long-Term Leases	-	-	-	-	0.01	-
Other Long-Term Liabilities	-	-	-	-	-	0.14
Total Liabilities	1.45	1.23	1.36	1.05	0.76	0.49
Common Stock	9.7	9.7	9.7	9.7	9.7	9.7
Retained Earnings	-12.45	-12.2	-12.13	-7.74	-6.66	-5.01
Comprehensive Income & Other	1.32	1.32	1.29	1.23	0.97	0.17
Shareholders' Equity	-1.43	-1.18	-1.14	3.2	4.01	4.86
Total Liabilities & Equity	0.03	0.05	0.22	4.25	4.77	5.35
Total Debt	1.02	0.82	0.51	0.18	0.05	0.02
Net Cash (Debt)	-1.02	-0.8	-0.5	-0.17	0.09	0.68
Net Cash Growth	-	-	-	-	-86.81%	6230.58%
Net Cash Per Share	-0.02	-0.01	-0.01	-0.00	0.00	0.01
Filing Date Shares Outstanding	59.22	59.22	59.22	59.22	59.22	59.22
Total Common Shares Outstanding	59.22	59.22	59.22	59.22	59.22	59.22
Working Capital	-1.43	-1.19	-1.15	-0.81	-0.56	0.37
Book Value Per Share	-0.02	-0.02	-0.02	0.05	0.07	0.08
Tangible Book Value	-1.43	-1.19	-1.15	-0.81	-0.53	0.23
Tangible Book Value Per Share	-0.02	-0.02	-0.02	-0.01	-0.01	0.00

Source: S&P Global Market Intelligence. Standard template. Financial Sources.